|Articles|October 1, 2012
- BioPharm International-10-01-2012
- Volume 25
- Issue 10
BioPharm International, October 2012 Issue (PDF)
Vaccine Packaging and Delivery Systems
Advertisement
Articles in this issue
over 13 years ago
India Enforces Stricter Patent Lawsover 13 years ago
A Manufacturing-Capacity Sharing Modelover 13 years ago
FDA and the Importance of Confidentialityover 13 years ago
New Era for Generic Drugsover 13 years ago
Discovery Pipeline: Nanoparticles for Targeted Deliveryover 13 years ago
Considerations in Vaccine Packaging and Delivery Systemsover 13 years ago
Sizing the Market for Contract Manufacturingover 13 years ago
Bringing Innovation to Neglected Disease R&DNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
FDA October 2025 Draft Guidance Sparks Industry Biosimilars Buzz
2
GSK Acquisition of RAPT Signals Shift Toward Long-Acting Anti-IgE Therapies
3
EC’s High-Dose Aflibercept Approval Highlights Durable Anti-VEGF Retinal Therapy
4
How Biopharma Navigates the 2026 Economic Shift
5
